Clinical Microbiology Market Size to Reach USD 6.6 Billion in 2028, Noted Reports and Data

Rising prevalence of infectious diseases including SARS-CoV-2 infection and technological advancements in diseases diagnostics to spur market growth

The global clinical microbiology market size is expected to reach USD 6.6 billion by 2028 at a CAGR of 6.7%, according to the latest report by Reports and Data. The global market growth is majorly accelerated by rising prevalence of infectious diseases, growing demand for early detection of infectious diseases, and technological upgrading in disease diagnostics. Other essential factors driving market growth are increasing research activities to develop pathogen-specific diagnostic kits, growing adoption of advanced genomic techniques, increasing usage of clinical microbiology products across clinical diagnostic centers and research laboratories, and rising government investments for pharmaceutical development.

Clinical microbiology is the division of microbiology that studies infections causing microbes in the human body. It involves accurate diagnosis and management of infectious diseases and requires testing of bodily fluid samples to identify microorganisms, such as bacteria, viruses, fungi, and parasites, which lead to infection. It aids in rapid diagnosis of pathogens and ensures effective administration of antibiotics to enhance treatment results. It also uses several advanced diagnostic methods, such as MALDI–TOF mass spectrometry, real-time genome sequencing, and phenotypic microarrays, for sampling and analysis processes.

Access Free sample PDF Copy of the Report @ 

Key Highlights of the Report:

  • In terms of application, the pharmaceutical applications segment is expected to retain the highest revenue share over the forecast years. Rising development of pharmaceutical drugs and increasing focus of pharmaceutical companies on sterile manufacturing of excipients and APIs are expected to bolster the growth of this segment.
  • Hospitals & diagnostic centers is the leading end-user segment in the global clinical microbiology market. Rising prevalence target diseases, such as malaria and HIV-AIDS, and growing adoption of advanced molecular diagnostic products including NGS and PCR instruments are pivotal factors propelling the growth of this segment.
  • The North America clinical microbiology market is the most dominant regional market with fastest revenue growth rate. Market growth in this region is attributed to escalating demand for advanced diagnostic technologies and growing use of these technologies across research laboratories and diagnostic centers, and increased public and private funding for healthcare infrastructure development.
  • Leading players in the global clinical microbiology market are Abbott Laboratories, Thermo Fisher Scientific Inc., BioMérieux, Bruker Corporation, Danaher Corporation, Roche Diagnostics, Bio-Rad Laboratories Inc., Becton, Dickinson and Company, QIAGEN, Hologic Inc., Arrow Diagnostics, Merck KGaA, 3M, Memmert, Agilent Technologies, Hardy Diagnostics, Liofilchem, Biotechnology Solutions, New Horizons, NEOGEN Corporation, Shimadzu Corporation, TCS Biosciences, Rapid Micro Biosystems, Vacutest Kima, and OpGen.

Buy now your Exclusive copy of Report @

For the purpose of this report, the global clinical microbiology market is segmented based on laboratory instrument type, reagent type, disease type, application, end-user, and region:

By Laboratory Instrument Type (Revenue, USD Billion; 2018-2028)

  • Incubators
  • Gram Stainers
  • Petri Dish Fillers
  • Microbial Air Samplers
  • Blood Culture Systems
  • Autoclave Sterilizers
  • Bacterial Colony Counters
  • Anaerobic Culture Systems
  • Microbial Analyzers
  • Molecular Diagnostics Instruments
  • Mass Spectrometers
  • Microscopes
  • Others

By Reagent Type (Revenue, USD Billion; 2018-2028)

  • Pathogen-specific Kits
  • General Reagents
  • Others

By Disease Type (Revenue, USD Billion; 2018-2028)

  • Bloodstream Infections
  • Respiratory Diseases
  • Gastrointestinal Diseases
  • Sexually Transmitted Diseases
  • Periodontal Diseases
  • Urinary Tract Infections
  • Others

Request for Custom Research @

By Application (Revenue, USD Billion; 2018-2028)

  • Pharmaceutical Applications
  • Food Testing Applications
  • Clinical Applications
  • Energy Applications
  • Environmental Applications
  • Chemical & Material Manufacturing Applications
  • Others

By End-user (Revenue, USD Billion; 2018-2028)

  • Hospitals & Diagnostics Centers
  • Custom Laboratory Service Providers
  • Academic & Research Institutes
  • Others

By Region (Revenue, USD Billion; 2018-2028)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of the Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Rest of the Middle East & Africa

Explore Reports and Data's Prime Analysis of the global Pharmaceutical & Healthcare Industry:

Viral Molecular Diagnostics Market Share & Trends Analysis by Virus Type (Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV), Others), by Application (Infectious Diseases, Genetics, Blood Screening, Microbiology, Others), by End-User (Hospitals, Laboratories, Academic Institutions, Others), Region, Competitive Strategies and Segment Forecasts, 2016- 2026

In-Vitro Diagnostics Market Size, Share & Analysis, By Product Type (Instruments, Data Management Software, Reagents & kits, Services), By Technology (Immunochemistry/Immunoassay, Clinical Chemistry, Molecular Diagnostics, Coagulation & Hemostasis, Hematology, Microbiology, Urinalysis, Others), By Usability (Reusable IVD Devices, Disposable IVD Devices), By Application (Diabetes, Oncology/Cancer, Infectious Diseases, Autoimmune Diseases, Cardiology, Nephrology, HIV/AIDS, Drug Testing/Pharmacogenomics, Others), By End-user (Hospitals, Laboratories, Home Care, Point-Of-Care Testing, Patient Self-Testing, Academic & Research Institutes, Others), And By Region, Forecast To 2028

Sepsis Diagnostics Market Size, Growth & Analysis, By Product Type (Blood Culture Media, Assays & Reagents, Instruments, Software, Others), By Technology Type (Microbiology, Molecular, Diagnostics, Immunoassays, Flow Cytometry, Microfluidics, Biomarkers), By Pathogens Type (Bacterial, Fungal), By Method Type (Conventional, Automated), By Test Type (Laboratory Tests), By End Use (Hospital, Clinic, Others), Forecasts To 2027

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web:

Direct Line: +1-212-710-1370


Read Full Press Release:

Back to news